-
Morgan Stanley Resumes Lakefront Biotherapeutics (LKFT) at Equalweight
-
Lakefront Biotherapeutics launches €50 million share buyback program
-
Lakefront Biotherapeutics appoints Eric Hedrick as chief medical officer
-
Bank of America crosses 5% threshold in Lakefront Biotherapeutics


